Crescita Therapeutics, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA2258471028
CAD
0.44
0.02 (4.76%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1111331,
    "name": "Crescita Therapeutics, Inc.",
    "stock_name": "Crescita Therapeutics, Inc.",
    "full_name": "Crescita Therapeutics, Inc.",
    "name_url": "stocks-analysis/crescita-therapeutics-inc",
    "exchange": 30,
    "exchangecode": "TSE",
    "country_id": 1,
    "currency": "CAD",
    "cmp": "0.44",
    "chg": 0.02,
    "chgp": "4.76%",
    "dir": 1,
    "prev_price": "0.42",
    "mcapval": "8.95",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P/TSX 60",
    "isin": "CA2258471028",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.0 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/crescita-therapeutics-inc-1111331-30&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Crescita Therapeutics Adjusts Valuation Amid Strong Sales Growth and Market Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/crescita-therapeutics-receives-stock-upgrade-amid-strong-sales-growth-and-profitability-improvements-3690008",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CrescitaTherape_mojoScore_3690008.png",
        "date": "2025-11-11 16:26:05",
        "description": "Crescita Therapeutics, Inc. has recently experienced a change in its evaluation, highlighting its financial metrics and market position. The company reported a 52.47% increase in net sales for the quarter ending June 2025 and achieved its highest operating cash flow, indicating effective cash management amidst a complex financial landscape."
      }
    ],
    "total": 1,
    "sid": "1111331",
    "stock_news_url": "https://www.marketsmojo.com/news/crescita-therapeutics-inc-1111331"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available